Biology-based technology company developing an AI-powered precision therapeutics platform for acute and critical illness
Biology-based technology company developing an AI-powered precision therapeutics platform for acute and critical illness. Its Immunix platform combines a large longitudinal biobank, multimodal patient data, proprietary biomarker assays, and EHR integration to develop and clinically validate AI biomarkers and diagnostics, including Sepsis ImmunoScore, an FDA-authorized AI diagnostic for sepsis. The platform supports identifying which patients are likely to respond to specific treatments and aims,